Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412134 | SCV000487477 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2015-12-28 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410160 | SCV000487478 | likely pathogenic | Peroxisome biogenesis disorder 1B | 2015-12-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002523885 | SCV002942570 | pathogenic | Zellweger spectrum disorders | 2023-05-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 371699). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln713*) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596, 26387595, 31831025). |
Baylor Genetics | RCV003475978 | SCV004203263 | likely pathogenic | Heimler syndrome 1 | 2023-10-21 | criteria provided, single submitter | clinical testing |